Navigation Links
Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
Date:3/4/2009

GORDONSVILLE, Va., March 4 /PRNewswire/ -- A new study by researchers at Harvard Medical School has found that combining essential B vitamins, including B6, B12, and folic acid, lower risk of developing age-related macular degeneration (AMD), one of the leading causes of vision loss among older Americans. These ingredients, which are formulated in combination with key omega-3 fatty acids and phytosterols, are also contained in the prescription supplement Animi-3, which is actively being prescribed by physicians to address deficiencies in these nutrients.

In the randomized, double-blind clinical trial, more than 5,000 women with heart disease, and at least three risk factors for cardiovascular disease, were given vitamins B6, B12, and folic acid over a seven-year time period. At the end of the trial, approximately 34 percent of the women had a lower risk of developing any type of AMD, while 41 percent had a lower risk of more severe forms of AMD.

"What's interesting here is the study authors note the correlation between age-related macular degeneration and cardiovascular disease," said nutritional expert Dr. Barbara Levine, Weill Cornell Medical College. "I recommend patients with nutritional deficiencies speak to their physicians about Animi-3, which is formulated with these essential B vitamins and DHA, the most important omega-3 fat, to address various conditions, including heart disease, arthritis, eye health, and depression."

"DHA is highly concentrated in the retina of the eye, which is one of the reasons why a DHA deficiency may be important to vision," added President Jack Schramm, PBM Pharmaceuticals, Inc., the makers of Animi-3. "Animi-3 delivers DHA as well as B6, B12, and folic acid. Studies continue to suggest that DHA, along with a combination of vitamins B6, B12, and folic acid, can address deficiencies in these nutrients associated with eye problems, including dry eye and macular hea
'/>"/>

SOURCE PBM Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
2. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
3. Testosterone May Improve Mental Function, From the Harvard Mens Health Watch
4. Your Hearing May be at Risk, Says Harvard Mens Health Watch
5. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
6. Tone Deafness Explained, from the Harvard Health Letter
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
11. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire-FirstCall/ -- ERT (Nasdaq: ERES ), anno...any,s President and CEO, and Keith Schneck, the Co...duled to present at the 21st Annual Piper Jaffray ...1, 2009 in New York City, New York. ,, Interest... the Company,s corporate website at http://www.er...
(Date:11/25/2009)...ire/ -- BioTrends Research Group, Inc. released Wa...rt, the first in a multi-phase syndicated market r...tho-Biotech,s Stelara, from product launch through...of the report provides quantitative information fr...ation from a subset of 20. The reports assess tri...
(Date:11/25/2009)... 25 For many of the mill... 27 million living with untreated hearing loss , ...logist Cindy Beyer. ,, Dr. Beyer, senior vice p...s largest hearing care and hearing aids companie..., frustration, and social isolation, "which can ea...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3MAQUET Cardiovascular Awarded New Contract by Novation 51197 1MAQUET Cardiovascular Awarded New Contract by Novation 51197 2Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration 12954 1Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration 12954 2IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 1IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 2
...ADELPHIA, May 22 Shire plc (LSE: SHP, Nasdaq: ...ompany, announced results of a study showing that ... (lisdexamfetamine dimesylate) CII with the proton... X 2), did not alter the median time it took for m...be reached in the subjects evaluated. In the same...
... ALTO, Calif., May 21 Telik, Inc. (Nasdaq: TELK...mized clinical study of canfosfamide (TELCYTA(R), ...xorubicin (PLD) vs. PLD will be presented at the 4...ical Oncology (ASCO) which will be held from May 2...esentation are as follows: , , , -- Abs...
Other Medicine Technology:New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8
(Date:11/27/2009)...ire-USNewswire/ -- Considered a highly risky and c...solid organ transplantation is now a life-saving m...n and women who gathered at the Winspear Opera Hou...m medical centers around the world to celebrate th...nstitute (BRTI), one of the pioneers of solid orga...
(Date:11/27/2009)...ov. 27 Shamir Optical In...ng provider of innovative products and technology ...t its board of directors had declared a dividend d...on (approximately NIS 37.62 million based on the N... or approximately US$ 0.609 (approximately NIS 2.3...
(Date:11/27/2009)... Nov. 27 Allrecipes.com , the w...ving traffic numbers, with more than 2.8 million v...lear picture of what was served on the biggest foo...al in 2009 weighed in at 2,225 calories per servin...cording to the Allrecipes site, Sweet Potato Pie ...
(Date:11/27/2009)...interactive anatomy education apps from Modality a... sciences learning opportunities for iPhone and iP...cus) November 27, 2009 -- Modality, Inc. and Lip...f Wolters Kluwer Health, today announced the avail... App Store. Clemente’s Anatomy, Rohen’...
(Date:11/26/2009)...thiomolybdate (TM) has been shown in studies to be...isease caused by an overload of copper, and certai...tle, however, is known about how the drug works at...western University researchers now has provided an...of TM bound to copper-loaded metallochaperones. Th...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...H, Minn., April 29 ev3 Inc. (Nasdaq:,EVVV) today ...ef executive,officer, is scheduled to present at t...uesday, May 13, 2008 at 4:00 p.m. PT (7:00 p.m. ET...t, go to the investors, section of the ev3 Web sit...
...tate contracts EDS interChange System to manage na...program, New IT solution will administer payments ...th records, help state identify health trends and ...ents, has been awarded a,seven-year, $391 million ...
...rphy Appointed as New Senior Vice President of Con... Pharsight,Corporation (Nasdaq: PHST ), a leadin...regulatory services for optimizing clinical drug,d...es. In this role, Dr. Murphy will lead the Company...
...LE, Tenn., April 29 With an 89% initial success,r...ggressive cancers, a,Nashville-based treatment is ...cording to NeoPlas Innovation Director of Research...en effective,for malignant melanoma, as well as pa...
...rence Call to Occur on Wednesday, April 30 at 2 p....on, Inc.,(Nasdaq: VRML ), a molecular diagnostics... address the need for improved detection of periph...nce will take place on Wednesday, April 30 at 2 p....
...TOWNSHIP, Michigan, April 28 Nearly ten years,aft... three years after FDA,approval, LASIK surgery is ...ered complications or experienced poor outcomes., ...n, to pain, to severe activity-limiting visual hal...
Other Medicine News:Health News:EDS Returns to Georgia With $391 Million Medicaid Win 2Health News:EDS Returns to Georgia With $391 Million Medicaid Win 3Health News:Pharsight Strengthens Senior Management Team 2Health News:Pharsight Strengthens Senior Management Team 3Health News:New Treatment Offers Hope for Beating Aggressive Cancers 2Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 2Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 3Health News:Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program 4Health News:FDA Examines LASIK Surgery Complications 2
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: